Holocene Advisors LP Grows Stock Holdings in Chemed Co. (NYSE:CHE)

Holocene Advisors LP raised its position in shares of Chemed Co. (NYSE:CHEFree Report) by 14.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,470 shares of the company’s stock after buying an additional 1,353 shares during the period. Holocene Advisors LP owned about 0.07% of Chemed worth $6,292,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. GAMMA Investing LLC boosted its holdings in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust purchased a new position in Chemed in the third quarter valued at $61,000. Mather Group LLC. boosted its holdings in Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the period. Quarry LP boosted its holdings in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the period. Finally, Sound Income Strategies LLC purchased a new stake in Chemed during the 3rd quarter worth about $201,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on CHE shares. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Read Our Latest Stock Report on Chemed

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,845 shares of company stock worth $3,978,798. Corporate insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $569.80 on Thursday. The business has a 50-day moving average of $576.77 and a two-hundred day moving average of $565.09. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The company has a market capitalization of $8.58 billion, a price-to-earnings ratio of 28.79, a price-to-earnings-growth ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHEGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter last year, the firm posted $5.32 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, equities research analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.